::: Addex to Host R&D Day on July 16
development of allosteric modulators, current views of Addex Pharmaceuticals, allosteric modulators of mGluR2, lead allosteric modulator product, Allosteric modulation company, clinical-stage products ADX10059, forward-looking statements, Geneva Switzerland, available small molecule therapeutic agent

::: NorDiag: successful completion of clinical trial for NorDiag's new Bullet Bugs'n Beads(TM) kit
multi application kit, multi kit, successful completion of clinical trial, sample preparation of different clinical samples, difficult clinical samples, new Bullet Bugs, clinical study met, similar applications, CEO Mårten Wigst, biotechnology company developing

::: Sorin Group Announces Regulatory Approval and First Implants of New-Platform FACIL and REPLY Pacemakers in Japan
first FACIL pacemaker, FACIL families, REPLY families of pacemakers, latest Sorin Group technology, REPLY Pacemakers, latest generation pacing platform, pacemaker families offer advanced therapy options, First Implants of New-Platform FACIL, unselected AV Block patients.1 Unnecessary pacing, success of the REPLY family

::: Silicos, a computational drug design biotech, appoints Dr. Jack Elands as chief business officer
computational drug design biotech, computational drug design methods, computational fragment based drug design platforms, PTP-1B drug development programs, internal drug development programs, drug development process, drug targets, Jack Elands, generating novel chemical structures, Chief Business Officer

::: Merck KGaA Appoints François Naef as General Counsel
Merck Serono, umbrella of Merck KGaA, Merck Website, Merck family, subsidiary Merck, Merck Press Releases, François Naef, Group General Counsel, Head of Corporate Legal, independent company